Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challenge

BACKGROUND: Ebola virus (EBOV), variant Makona, was the causative agent of the 2013–2016 West African epidemic responsible for almost 30,000 human infections and over 11,000 fatalities. During the epidemic, the development of several experimental vaccines was accelerated through human clinical trial...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :EBioMedicine
Главные авторы: Marzi, Andrea, Reynolds, Pierce, Mercado-Hernandez, Reinaldo, Callison, Julie, Feldmann, Friederike, Rosenke, Rebecca, Thomas, Tina, Scott, Dana P., Hanley, Patrick W., Haddock, Elaine, Feldmann, Heinz
Формат: Artigo
Язык:Inglês
Опубликовано: Elsevier 2019
Предметы:
Research paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6945200/
https://ncbi.nlm.nih.gov/pubmed/31631035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2019.09.055
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы